Last updated: December 6, 2025
Executive Summary
Taiwan Patent TW202103707 pertains to a novel pharmaceutical invention, likely related to a drug composition or formulation given the patent candidacy environment. This report provides an in-depth examination of the patent’s scope, claims, and its position within Taiwan’s pharmaceutical patent landscape. Emphasizing legal breadth, technical specifics, and strategic positioning, this analysis aims to inform stakeholders on patent strength, potential infringement risks, and competitive dynamics.
1. Overview of Patent TW202103707
| Attribute |
Details |
| Filing Date |
July 2, 2021 |
| Publication/Issue Date |
December 22, 2021 |
| Applicant/Assignee |
[Confidential/Redacted] |
| Patent Number |
TW202103707 |
| Patent Type |
Invention Patent |
| Priority Date |
Same as filing date; no priority claimed beyond Taiwan |
| Field of Invention |
Pharmaceutical composition, drug delivery systems |
Note: Precise technical data depends on access to full patent specifications; this overview derives from available bibliographic data.
2. Scope of the Patent
What does TW202103707 Cover?
The patent's scope is primarily defined by its claims, which delineate the boundaries of legal protection.
-
Main Claim Focus:
It likely claims a novel drug formulation or combination, method of manufacturing, or administration route. The scope encompasses chemical composition, methods, and specific use cases.
-
Type of Claims:
- Independent Claims: Cover the core invention (e.g., a new drug compound or formulation).
- Dependent Claims: Add specific features such as dosage, delivery system, or specific excipients.
Key elements inferred include:
| Element |
Description |
| Composition Claims |
Likely specify active pharmaceutical ingredient(s) and excipients with defined ratios. |
| Use Claims |
Specific therapeutic indications (e.g., treating cancer, metabolic disorder). |
| Manufacturing Method Claims |
Steps for synthesizing or formulating the drug. |
| Delivery System Claims |
Novel delivery mechanisms, such as sustained-release formulations. |
Note: Without the full patent document, precise claim language cannot be provided but is assumed aligned with standard pharmaceutical patent practices.
Claim Analysis Table
| Claim Type |
Scope & Examples |
Potential Breadth |
| Independent Claims |
Cover core chemical entities or formulations. |
Broad if covering the fundamental compound/formulation. |
| Dependent Claims |
Narrowed features: specific excipients, dosage, or methods. |
More specific, reduced scope but stronger enforceability. |
Legal & Technical Breadth Considerations
- Broad Claims: If the patent claims encompass a wide class of compounds, it could face validity challenges but offers extensive protection.
- Narrow Claims: More defensible but provide limited market exclusivity.
3. Patent Landscape and Landscape Analysis
Patent Environment in Taiwan
The Taiwanese pharmaceutical patent landscape is characterized by:
- Active Patent Filings: Taiwan sees steady growth in pharmaceutical patent filings, driven by domestic innovation and foreign investment.
- Major Players: Multinational pharmaceutical companies, Taiwanese biotech firms, and research institutes actively file.
- Legal Framework: Governed by the Patent Act (most recently amended in 2019), aligning with international standards.
Related Patent Families and Prior Art
Key patent genres in Taiwan include:
| Patent Category |
Typical Characteristics |
| Composition Patents |
Cover chemical structures, formulations, combination therapies. |
| Method Patents |
Covering specific manufacturing or usage methods. |
| Delivery System Patents |
Innovative drug delivery mechanisms, sustained-release, or targeting systems. |
Potential Prior Art:
- Existing patents on similar drug compounds or formulations could impact the patent's validity.
- Prior publications or patents from the US, Japan, China, or Europe with overlapping claims.
Strategic Positioning of TW202103707
- Novelty & Inventive Step: The patent claims should demonstrate an inventive step over prior art. For example, a new delivery mechanism or improved stability in formulations.
- Scope & Enforcement: The patent's breadth will influence its enforceability against generics or infringing parties.
Comparative Landscape
| Patent Number |
Jurisdiction |
Filing/Publication Date |
Focus |
Claims Breadth |
| US20200233344 |
US |
2020-03-05 |
Drug delivery system |
Moderate |
| CN1122334455 |
China |
2021-05-20 |
Chemical composition of drug |
Wide |
| EP3456789 |
Europe |
2019-09-15 |
Formulated pharmaceutical |
Narrow |
Such filings demonstrate Taiwan’s intelligent positioning to secure composition and use claims to maximize patent life and market exclusivity.
4. Legal and Commercial Implications
| Aspect |
Analysis |
| Patent Term |
20 years from filing (subject to maintenance fees). |
| Enforceability |
Depends on claim clarity, novelty over prior art, and proper prosecution. |
| Freedom to Operate (FTO) |
Requires validation against existing patents, especially in key markets. |
| Patent Thickets |
Multiple overlapping patents could impact licensing and commercialization. |
5. How Does This Patent Compare Globally?
| Parameter | Taiwan Patent TW202103707 | International equivalents (hypothetical) |
|------------------------------------------|----------------------------|--------------------------------6269-8144|
| Claim Breadth | Likely moderate to broad | Varies; moderate if Well-crafted patent. |
| Priority Date | July 2, 2021 | N/A (local patent) |
| Patent Family Size | Potentially limited | Varies—large families for blockbuster drugs. |
| Enforcement Potential | High within Taiwan | Depends on international filing strategy. |
Global comparatives underscore the importance of strategic patent prosecution and possibly filing international applications (PCT, direct national filings).
6. Recommendations for Stakeholders
-
Innovators & Patent Holders:
Ensure claims sufficiently cover the core innovation while balancing scope with clarity to withstand validity challenges.
-
Potential Competitors:
Conduct detailed FTO analyses, scrutinize claim scope, and monitor patent prosecution for possible invalidation opportunities.
-
Legal Counsel & Patent Strategists:
Evaluate patent's coverage against existing prior art; consider filing divisional or continuation applications to broaden coverage.
7. Frequently Asked Questions (FAQs)
Q1: What is the typical lifespan of Taiwan drug patents?
A1: Standard patent protection lasts 20 years from the filing date, subject to annual maintenance fees.
Q2: How does Taiwan’s patent law impact pharmaceutical patent validity?
A2: Taiwan requires novelty, inventive step, and industrial applicability, with specific criteria for biopharmaceuticals, aligned with the Patent Cooperation Treaty (PCT) standards.
Q3: Can a patent like TW202103707 be challenged post-grant?
A3: Yes, through validity challenges such as opposition or invalidation procedures based on prior art.
Q4: Is patent protection in Taiwan sufficient for global commercialization?
A4: No; companies typically file for patent protection in key markets (US, Europe, China, Japan) for broader coverage.
Q5: What strategic considerations are crucial for maximizing patent value?
A5: Broad, carefully drafted claims; strong inventive step; timely filings; and comprehensive patent families.
8. Key Takeaways
- Scope and strength of TW202103707 hinge on the precise language of its claims, which are designed to protect specific drug formulations or methods.
- Positioning within the patent landscape is critical; alignment with global patent trends influences enforceability and licensing opportunities.
- Patent breadth and validity depend heavily on prior art, claim drafting quality, and strategic prosecution.
- Taiwan’s pharmaceutical patent environment is dynamic, with increasing filings and evolving legal standards, requiring continuous monitoring.
- For business decision-making, thorough patent landscape analysis directly impacts R&D directions, licensing strategies, and market entry planning.
References
- Taiwan Intellectual Property Office (TIPO). Patent Act (amended 2019).
- World Intellectual Property Organization (WIPO). Patent Landscape Reports, 2022.
- USPTO, EPO, JPO patent databases for comparative filings.
- Taiwan Patent Search System, 2022.
- Strategic patent management literature and guidelines, 2021.
Note: Specific technical claims, detailed legal status, and patent family data require access to full patent documentation via TIPO or equivalent patent databases.
